Northern Trust’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-113,887
Closed -$268K 4538
2024
Q3
$268K Buy
113,887
+13,818
+14% +$27.9K ﹤0.01% 3782
2024
Q2
$88.1K Sell
100,069
-723
-0.7% -$1.49K ﹤0.01% 4078
2024
Q1
$412K Buy
100,792
+16,104
+19% +$72.1K ﹤0.01% 3625
2023
Q4
$495K Buy
84,688
+20,544
+32% +$108K ﹤0.01% 3541
2023
Q3
$330K Buy
64,144
+19,205
+43% +$90.1K ﹤0.01% 3633
2023
Q2
$216K Buy
44,939
+4,434
+11% +$15.3K ﹤0.01% 3797
2023
Q1
$70.5K Buy
40,505
+6,861
+20% +$11.2K ﹤0.01% 4173
2022
Q4
$52.5K Hold
33,644
﹤0.01% 4272
2022
Q3
$49K Hold
33,644
﹤0.01% 4328
2022
Q2
$61K Buy
33,644
+1,822
+6% +$4.22K ﹤0.01% 4345
2022
Q1
$94K Buy
31,822
+167
+0.5% +$453 ﹤0.01% 4364
2021
Q4
$100K Buy
+31,655
New +$115K ﹤0.01% 4427

Northern Trust's AUGX Position: Q4 2024 in Review

Northern Trust sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 113,887 shares — an estimated $268K sold.

Northern Trust first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $495K in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Northern Trust reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Northern Trust sold 113,887 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $268K.
  • Northern Trust first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Northern Trust's Augmedix, Inc. Common Stock position peaked at $495K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.